Tamiflu, Relenza Labels Adjusted To Cite Influenza As Potential Cause Of Neuro Events
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche says label change for Tamiflu reflects growing evidence there is no causal relationship between the drug and neuropsychiatric events.